These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 12102620

  • 1. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D, de Suray JM, Vandenhende F, Onkelinx C, Gangji D.
    AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
    [Abstract] [Full Text] [Related]

  • 2. A novel augmentation strategy for treating resistant major depression.
    Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, Buras WR, Bymaster FP, Zhang W, Spencer KA, Feldman PD, Meltzer HY.
    Am J Psychiatry; 2001 Jan; 158(1):131-4. PubMed ID: 11136647
    [Abstract] [Full Text] [Related]

  • 3. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC.
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [Abstract] [Full Text] [Related]

  • 4. Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.
    Corya SA, Andersen SW, Detke HC, Kelly LS, Van Campen LE, Sanger TM, Williamson DJ, Dubé S.
    J Clin Psychiatry; 2003 Nov; 64(11):1349-56. PubMed ID: 14658950
    [Abstract] [Full Text] [Related]

  • 5. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E, Braus DF, Cavus I, Thome J.
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [Abstract] [Full Text] [Related]

  • 6. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
    Matthews JD, Bottonari KA, Polania LM, Mischoulon D, Dording CM, Irvin R, Fava M.
    J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
    [Abstract] [Full Text] [Related]

  • 7. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF.
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.
    Koran LM, Ringold AL, Elliott MA.
    J Clin Psychiatry; 2000 Jul; 61(7):514-7. PubMed ID: 10937610
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.
    Owen RT.
    Drugs Today (Barc); 2006 Mar; 42(3):185-92. PubMed ID: 16628260
    [Abstract] [Full Text] [Related]

  • 11. [Olanzapine: pharmacology, pharmacokinetics and therapeutic drug monitoring].
    Rao ML, Hiemke C, Grasmäder K, Baumann P, TDM Arbeitsgruppe Der AGNP.
    Fortschr Neurol Psychiatr; 2001 Nov; 69(11):510-7. PubMed ID: 11704898
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
    Potenza MN, Wasylink S, Longhurst JG, Epperson CN, McDougle CJ.
    J Clin Psychopharmacol; 1998 Oct; 18(5):423-4. PubMed ID: 9790164
    [No Abstract] [Full Text] [Related]

  • 13. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN, Wasylink S, Epperson CN, McDougle CJ.
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract] [Full Text] [Related]

  • 14. Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.
    Detweiler MB, Trinkle DB.
    J Clin Psychiatry; 2003 Jul; 64(7):851-2. PubMed ID: 12934994
    [No Abstract] [Full Text] [Related]

  • 15. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.
    Poyurovsky M, Pashinian A, Gil-Ad I, Maayan R, Schneidman M, Fuchs C, Weizman A.
    Am J Psychiatry; 2002 Jun; 159(6):1058-60. PubMed ID: 12042201
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.
    Zhang W, Perry KW, Wong DT, Potts BD, Bao J, Tollefson GD, Bymaster FP.
    Neuropsychopharmacology; 2000 Sep; 23(3):250-62. PubMed ID: 10942849
    [Abstract] [Full Text] [Related]

  • 17. Focus on olanzapine.
    Green B.
    Curr Med Res Opin; 1999 Sep; 15(2):79-85. PubMed ID: 10494490
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [Abstract] [Full Text] [Related]

  • 19. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
    Francobandiera G.
    Can J Psychiatry; 2001 May; 46(4):356-8. PubMed ID: 11387793
    [Abstract] [Full Text] [Related]

  • 20. Melancholic symptoms during concurrent olanzapine and fluoxetine.
    Nelson LA, Swartz CM.
    Ann Clin Psychiatry; 2000 Sep; 12(3):167-70. PubMed ID: 10984007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.